• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

熊果酸通过减轻内质网应激抑制非酒精性脂肪性肝病的发生。

Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress.

机构信息

College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, P. R. China.

出版信息

Food Funct. 2015 May;6(5):1643-51. doi: 10.1039/c5fo00083a.

DOI:10.1039/c5fo00083a
PMID:25892149
Abstract

Ursolic acid (UA) is a natural pentacyclic triterpenoid compound, which is enriched with many herbs and plants, such as apple, cranberry and olive. UA performs multiple biological activities including anti-oxidation, anti-inflammation, anti-cancer and hepatoprotection. However, the exact mechanism underlying the hepatoprotective activity of UA remains unclear. In this study, the effects of UA on the development of nonalcoholic fatty liver disease (NAFLD) were investigated. In vivo, UA treatment (0.14%, w/w) significantly decreased the liver weight, serum levels of ALT/AST and hepatic steatosis in db/db mice (a type 2 diabetic mouse model). In vitro, UA treatment (10-30 μg ml(-1)) significantly decreased palmitic acid induced intracellular lipid accumulation in L02 cells. Our results suggested that the beneficial effects of UA on NAFLD may be due to its ability to increase lipid β-oxidation and to inhibit the hepatic endoplasmic reticulum (ER) stress. Together, UA may be further considered as a natural compound for NAFLD treatment.

摘要

熊果酸(UA)是一种天然的五环三萜化合物,富含于多种草药和植物中,如苹果、蔓越莓和橄榄。UA 具有多种生物学活性,包括抗氧化、抗炎、抗癌和保肝。然而,UA 发挥保肝作用的确切机制尚不清楚。本研究探讨了 UA 对非酒精性脂肪性肝病(NAFLD)发展的影响。在体内,UA 处理(0.14%,w/w)显著降低了 db/db 小鼠(2 型糖尿病小鼠模型)的肝重、血清 ALT/AST 水平和肝脂肪变性。在体外,UA 处理(10-30μg/ml)显著降低了棕榈酸诱导的 L02 细胞内脂质堆积。我们的结果表明,UA 对 NAFLD 的有益作用可能与其增加脂质β氧化和抑制肝内质网(ER)应激的能力有关。总之,UA 可进一步被视为治疗 NAFLD 的天然化合物。

相似文献

1
Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress.熊果酸通过减轻内质网应激抑制非酒精性脂肪性肝病的发生。
Food Funct. 2015 May;6(5):1643-51. doi: 10.1039/c5fo00083a.
2
Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.熊果酸,一种新型肝 X 受体α(LXRα)拮抗剂,抑制配体诱导的非酒精性脂肪肝和药物诱导的脂肪生成。
J Agric Food Chem. 2018 Nov 7;66(44):11647-11662. doi: 10.1021/acs.jafc.8b04116. Epub 2018 Oct 25.
3
Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.别嘌醇通过调节脂代谢、炎症和内质网应激途径改善糖尿病大鼠高果糖饮食诱导的肝脂肪变性。
Sci Rep. 2021 May 10;11(1):9894. doi: 10.1038/s41598-021-88872-7.
4
Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress.熊果酸通过活性氧依赖的内质网应激诱导U87MG细胞自噬。
Chem Biol Interact. 2014 Jul 25;218:28-41. doi: 10.1016/j.cbi.2014.04.017. Epub 2014 May 5.
5
Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.非诺贝特治疗减轻了非酒精性脂肪性肝病小鼠肝脏中的慢性内质网应激。
Pharmacology. 2015;95(3-4):173-80. doi: 10.1159/000380952. Epub 2015 Apr 16.
6
GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease.GLP-1 受体激动剂:对非酒精性脂肪性肝病进展的影响。
Diabetes Metab Res Rev. 2015 May;31(4):329-35. doi: 10.1002/dmrr.2580. Epub 2014 Sep 14.
7
Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice.中岛豇豆提取物对高脂饮食喂养小鼠非酒精性脂肪性肝病的减轻作用。
Biosci Biotechnol Biochem. 2014;78(3):482-9. doi: 10.1080/09168451.2014.882753. Epub 2014 Apr 14.
8
Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway.苦参碱通过调节 SERCA 通路减轻非酒精性脂肪性肝病内质网应激和线粒体功能障碍。
J Transl Med. 2018 Nov 20;16(1):319. doi: 10.1186/s12967-018-1685-2.
9
Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.烟酸抑制培养肝细胞中的脂肪积累、氧化应激和炎性细胞因子白细胞介素-8:对非酒精性脂肪性肝病的影响。
Metabolism. 2015 Sep;64(9):982-90. doi: 10.1016/j.metabol.2015.05.002. Epub 2015 May 7.
10
Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice.阿佐酰胺可改善果糖诱导的小鼠非酒精性脂肪性肝病。
Tissue Cell. 2019 Aug;59:62-69. doi: 10.1016/j.tice.2019.07.001. Epub 2019 Jul 2.

引用本文的文献

1
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease.熊果酸靶向分泌磷蛋白 1 以调节 Th17 细胞对抗代谢功能障碍相关脂肪性肝病。
Clin Mol Hepatol. 2024 Jul;30(3):449-467. doi: 10.3350/cmh.2024.0047. Epub 2024 Apr 16.
2
Pharmacology of bioactive compounds from plant extracts for improving non-alcoholic fatty liver disease through endoplasmic reticulum stress modulation: A comprehensive review.通过内质网应激调节改善非酒精性脂肪性肝病的植物提取物生物活性化合物药理学:综述
Heliyon. 2024 Jan 23;10(3):e25053. doi: 10.1016/j.heliyon.2024.e25053. eCollection 2024 Feb 15.
3
; a biotechnological perspective on the coming-of-age prince's pine.
; 关于成年王子松的生物技术视角。
Phytochem Rev. 2023 Jun 8:1-16. doi: 10.1007/s11101-023-09880-1.
4
Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD.人参皂苷Rc作为一种新型的SIRT6激活剂,可保护小鼠免受高脂饮食诱导的非酒精性脂肪性肝病的影响。
J Ginseng Res. 2023 May;47(3):376-384. doi: 10.1016/j.jgr.2020.07.005. Epub 2020 Aug 4.
5
Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy.萜类化合物:非酒精性脂肪性肝病 (NAFLD) 治疗的天然化合物。
Molecules. 2022 Dec 29;28(1):272. doi: 10.3390/molecules28010272.
6
Quzhi Formula Alleviates Nonalcoholic Steatohepatitis by Impairing Hepatocyte Lipid Accumulation and Inflammation via Bip/eIF2α Signaling.祛脂方通过Bip/eIF2α信号通路减轻肝细胞脂质蓄积和炎症反应从而缓解非酒精性脂肪性肝炎。
J Clin Transl Hepatol. 2022 Dec 28;10(6):1050-1058. doi: 10.14218/JCTH.2021.00458. Epub 2022 Feb 24.
7
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Bunge.中药治疗非酒精性脂肪性肝病的治疗潜力:一种有前景的药物 远志。 (注:这里的“Bunge”可能是某种植物的拉丁名,比如远志属植物,具体需结合上下文准确判断,这里暂且直译为“远志” )
Acta Pharm Sin B. 2022 Sep;12(9):3529-3547. doi: 10.1016/j.apsb.2022.05.001. Epub 2022 May 11.
8
Electrospun Chitosan-Polyvinyl Alcohol Nanofiber Dressings Loaded with Bioactive Ursolic Acid Promoting Diabetic Wound Healing.负载具有促进糖尿病伤口愈合生物活性熊果酸的静电纺丝壳聚糖-聚乙烯醇纳米纤维敷料
Nanomaterials (Basel). 2022 Aug 25;12(17):2933. doi: 10.3390/nano12172933.
9
Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease.内质网应激介导的未折叠蛋白反应及内质网应激抑制剂在炎症性肠病发病机制中的作用。
Dig Dis Sci. 2022 Dec;67(12):5392-5406. doi: 10.1007/s10620-022-07467-y. Epub 2022 Mar 22.
10
Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.熊果酸在癌症和糖尿病性神经病疾病中的治疗潜力。
Int J Mol Sci. 2021 Nov 10;22(22):12162. doi: 10.3390/ijms222212162.